Nippon Life India Asset Management Ltd. - Nippon India Mutual Fund - Nippon India Nifty Pharma ETF (NSE:PHARMABEES)

Assets	5.44B
Expense Ratio	0.19%
PE Ratio	35.99
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+21.68%

Volume	3,305,177
Open	28.37
Previous Close	27.68
Day's Range	27.61 - 28.37
52-Week Low	21.46
52-Week High	28.40
Beta	0.19
Holdings	n/a
Inception Date	Jul 2, 2021

About PHARMABEES

PHARMABEES.NS was created on 2021-07-02 by Nippon. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PHARMABEES
• Provider: Nippon
• Index Tracked: Nifty Pharma Index - INR - Benchmark TR Gross

Performance

PHARMABEES had a total return of 21.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.43%.

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error